Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab vs Rituximab in Relapsed Rituximab-sensitive Follicular Lymphoma
CTR20130072Phase 3Suspended
- Sponsor
- GSK
- Start
- Jun 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of ofatumumab in follicular lymphoma (FL), sponsored by GSK. Started Jun 2016; status: suspended.
02
Drugs
ofatumumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on CTR20130072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130072.